Rhododendrol, a reductive metabolite of raspberry ketone, suppresses the differentiation of 3T3‑L1 cells into adipocytes

Uramaru,Naoto; Kawashima,Azusa; Osabe,Makoto; Higuchi,Toshiyuki

doi:10.3892/mmr.2023.12938

Rhododendrol, a reductive metabolite of raspberry ketone, suppresses the differentiation of 3T3‑L1 cells into adipocytes

Authors:
- Naoto Uramaru
- Azusa Kawashima
- Makoto Osabe
- Toshiyuki Higuchi
View Affiliations

Affiliations: Division of Pharmaceutical Health Biosciences, Nihon Pharmaceutical University, Saitama 362‑0806, Japan
Published online on: January 11, 2023 https://doi.org/10.3892/mmr.2023.12938
Article Number: 51
Copyright: © Uramaru et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Obesity is a serious medical condition worldwide, and a major risk factor for type 2 diabetes, metabolic syndrome, cancer and cardiovascular disease. In addition to changes in dietary habits and physical activity, consuming supplements to maintain good health and prevent obesity is important in modern society. Raspberry ketone (RK) is a natural phenolic ketone found in the European red raspberry (Rubus idaeus L.) and is hypothesized to prevent obesity when administered orally. The present study found that RK was reduced to rhododendrol (ROH) in human liver microsomes and cytosol. The present study investigated whether the metabolite ROH had anti‑adipogenic effects using mouse 3T3‑L1 cells. The effects of ROH or RK on lipid accumulation during differentiation of 3T3‑L1 pre‑adipocyte into adipocyte were determined using Oil Red O staining. CCAAT enhancer‑binding protein α (C/EBPα) and peroxisome proliferator‑activated receptor γ (PPARγ) mRNA and protein expression were examined using reverse transcription‑quantitative PCR and western blotting analysis, respectively. The present study revealed that ROH suppressed lipid accumulation in the cells, similar to RK. In addition, ROH suppressed the mRNA expression levels of C/EBPα and PPARγ in 3T3‑L1 adipocytes. Furthermore, ROH suppressed PPARγ protein expression in 3T3‑L1 adipocytes. These findings suggested that ROH is an active metabolite with an anti‑adipogenic effect, which may contribute to the anti‑obesity effect of orally administered RK. The present study indicated that it is important to understand the biological activity of the metabolites of orally administered compounds.

View Figures

View References

1	Ding J, Reynolds LM, Zeller T, Müller C, Lohman K, Nicklas BJ, Kritchevsky SB, Huang Z, de la Fuente A, Soranzo N, et al: Alterations of a cellular cholesterol metabolism network are a molecular feature of obesity-related type 2 diabetes and cardiovascular disease. Diabetes. 64:3464–3474. 2015. View Article : Google Scholar : PubMed/NCBI
2	Kopelman PG: Obesity as a medical problem. Nature. 404:635–643. 2000. View Article : Google Scholar : PubMed/NCBI
3	Garg SK, Maurer H, Reed K and Selagamsetty R: Diabetes and cancer: Two diseases with obesity as a common risk factor. Diabetes Obes Metab. 16:97–110. 2014. View Article : Google Scholar : PubMed/NCBI
4	Cao Z, Umek RM and McKnight SL: Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 5:1538–1552. 1991. View Article : Google Scholar : PubMed/NCBI
5	Farmer SR: Transcriptional control of adipocyte formation. Cell Metab. 4:263–273. 2006. View Article : Google Scholar : PubMed/NCBI
6	Morrison S and McGee SL: 3T3-L1 adipocytes display phenotypic characteristics of multiple adipocyte lineages. Adipocyte. 4:295–302. 2015. View Article : Google Scholar : PubMed/NCBI
7	Kim EJ, Kang MJ, Seo YB, Nam SW and Kim GD: Acer okamotoanum Nakai leaf extract inhibits adipogenesis via suppressing expression of PPAR γ and C/EBP α in 3T3-L1 cells. J Microbiol Biotechnol. 28:1645–1653. 2018. View Article : Google Scholar : PubMed/NCBI
8	Lee MS, Kim CT, Kim IH and Kim Y: Inhibitory effects of green tea catechin on the lipid accumulation in 3T3-L1 adipocytes. Phytother Res. 23:1088–1091. 2009. View Article : Google Scholar : PubMed/NCBI
9	Gallois A: Quantitative evaluation of raspberry ketone using thin-layer chromatography. Sci Aliments. 2:99–106. 1982.
10	Larsen M, Poll L, Callesen O and Lewis M: Relations between the content of aroma compounds and the sensory evaluation of 10 raspberry varieties (Rubus idaeus L). Acta Agric Scand. 41:447–454. 1991. View Article : Google Scholar
11	Mehanna ET, Barakat BM, El Sayed MH and Tawfik MK: An optimized dose of raspberry ketone controls hyperlipidemia and insulin resistance in male obese rats; Effect on adipose tissue expression of adipocytokines and aquaporin 7. Eur J Pharmacol. 832:81–89. 2018. View Article : Google Scholar : PubMed/NCBI
12	Wang L, Meng X and Zhang F: Raspberry ketone protects rats fed high-fat diets against nonalcoholic steatohepatitis. J Med Food. 15:495–503. 2012. View Article : Google Scholar : PubMed/NCBI
13	Morimoto C, Satoh Y, Hara M, Inoue S, Tsujita T and Okuda H: Anti-obese action of raspberry ketone. Life Sci. 77:194–204. 2005. View Article : Google Scholar : PubMed/NCBI
14	Fuchino H, Konishi S, Satoh T, Yagi A, Saitsu K, Tatsumi T and Tanaka N: Chemical evaluation of Betula species in Japan. II. Constituents of Betula platyphylla var japonica. Chem Pharm Bull. 44:1033–1038. 1996. View Article : Google Scholar
15	Inoue T, Ishidate Y, Fujita M, Kubo M, Fukushima M and Nagai M: Studies on the constituents of Aceraceae plants. I. Constituents in the leaves and the stem bark of Acer nikoense Maxim (author's transl). Yakugaku Zasshi. 98:41–46. 1978.(In Japanese). View Article : Google Scholar : PubMed/NCBI
16	Li X, Wei T, Wu M, Chen F, Zhang P, Deng ZY and Luo T: Potential metabolic activities of raspberry ketone. J Food Biochem. 46:e140182022.PubMed/NCBI
17	Sporstøl S and Scheline RR: The metabolism of 4-(4-hydroxyphenyl)butan-2-one (raspberry ketone) in rats, guinea-pigs and rabbits. Xenobiotica. 12:249–257. 1982. View Article : Google Scholar : PubMed/NCBI
18	Tanaka Y, Nishikawa Y, Matsuda K, Yamazaki M and Hayashi R: Purification and some properties of ketone reductase forming an active metabolite of sodium 2-[4-(2-oxocyclopentylmethyl)-phenyl]propionate dihydrate (loxoprofen sodium), a new anti-inflammatory agent, in rabbit liver cytosol. Chem Pharm Bull (Tokyo). 32:1040–1048. 1984. View Article : Google Scholar : PubMed/NCBI
19	Sasaki K, Yamauchi K and Kuwano S: Metabolic activation of sennoside A in mice. Planta Med. 37:370–378. 1979. View Article : Google Scholar : PubMed/NCBI
20	Murata H, Higuchi T and Otagiri M: Oral pharmacokinetics and in-vitro metabolism of metyrapone in male rats. J Pharm Pharmacol. 68:970–979. 2016. View Article : Google Scholar : PubMed/NCBI
21	Imamura Y, Iwamoto K, Yanachi Y, Higuchi T and Otagiri M: Postnatal development, sex-related difference and hormonal regulation of acetohexamide reductase activities in rat liver and kidney. J Pharmacol Exp Ther. 264:166–171. 1993.PubMed/NCBI
22	Higuchi T, Imamura Y and Otagiri M: Kinetic studies on the reduction of acetohexamide catalyzed by carbonyl reductase from rabbit kidney. Biochim Biophys Acta. 1158:23–28. 1993. View Article : Google Scholar : PubMed/NCBI
23	Imamura Y, Nozaki Y, Higuchi T and Otagiri M: Reactivity for prostaglandins and inhibition by nonsteroidal anti-inflammatory drugs of rabbit liver Befunolol reductase. Res Commun Chem Pathol Pharmacol. 71:49–57. 1991.PubMed/NCBI
24	Zhao D, Yuan B, Kshatriya D, Polyak A, Simon JE, Bello NT and Wu Q: Influence of diet-induced obesity on the bioavailability and metabolism of raspberry ketone (4-(4-hydroxyphenyl)-2-butanone) in mice. Mol Nutr Food Res. 64:e19009072020. View Article : Google Scholar : PubMed/NCBI
25	Kitayama T, Isomori S and Nakamura K: Asymmetric synthesis of enantiomerically pure zingerols by lipase-catalyzed transesterification and efficient synthesis of their analogues. Tetrahedron Asymmetry. 24:621–627. 2013. View Article : Google Scholar
26	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
27	Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ and Klenk DC: Measurement of protein using bicinchoninic acid. Anal Biochem. 150:76–85. 1985. View Article : Google Scholar : PubMed/NCBI
28	Leu SY, Chen YC, Tsai YC, Hung YW, Hsu CH, Lee YM and Cheng PY: Raspberry ketone reduced lipid accumulation in 3T3-L1 cells and ovariectomy-induced obesity in Wistar rats by regulating autophagy mechanisms. J Agric Food Chem. 65:10907–10914. 2017. View Article : Google Scholar : PubMed/NCBI
29	Tsai YC, Chen JH, Lee YM, Yen MH and Cheng PY: Raspberry ketone promotes FNDC5 protein expression via HO-1 upregulation in 3T3-L1 adipocytes. Chin J Physiol. 65:80–86. 2022. View Article : Google Scholar : PubMed/NCBI
30	Park KS: Raspberry ketone increases both lipolysis and fatty acid oxidation in 3T3-L1 adipocytes. Planta Med. 76:1654–1658. 2010. View Article : Google Scholar : PubMed/NCBI
31	Park KS: Raspberry ketone, a naturally occurring phenolic compound, inhibits adipogenic and lipogenic gene expression in 3T3-L1 adipocytes. Pharm Biol. 53:870–875. 2015. View Article : Google Scholar : PubMed/NCBI
32	Zhang Y, Proenca R, Maffei M, Barone M, Leopold L and Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature. 372:425–432. 1994. View Article : Google Scholar : PubMed/NCBI
33	Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK and Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 269:543–546. 1995. View Article : Google Scholar : PubMed/NCBI
34	Malátková P, Sokolová S, Chocholoušová Havlíková LC and Wsól V: Carbonyl reduction of warfarin: Identification and characterization of human warfarin reductases. Biochem Pharmacol. 109:83–90. 2016. View Article : Google Scholar : PubMed/NCBI
35	Matsumoto K, Hasegawa T, Koyanagi J, Takahashi T, Akimoto M and Sugibayashi K: Reductive metabolism of nabumetone by human liver microsomal and cytosolic fractions: Exploratory prediction using inhibitors and substrates as marker probes. Eur J Drug Metab Pharmacokinet. 40:127–135. 2015. View Article : Google Scholar : PubMed/NCBI
36	Arent SM, Walker AJ, Pellegrino JK, Sanders DJ, McFadden BA, Ziegenfuss TN and Lopez HL: The combined effects of exercise, diet, and a multi-ingredient dietary supplement on body composition and adipokine changes in overweight Adults. J Am Coll Nutr. 37:111–120. 2018. View Article : Google Scholar : PubMed/NCBI
37	White UA and Stephens JM: Transcriptional factors that promote formation of white adipose tissue. Mol Cell Endocrinol. 318:10–14. 2010. View Article : Google Scholar : PubMed/NCBI
38	Zhang BB, Zhou G and Li C: AMPK: An emerging drug target for diabetes and the metabolic syndrome. Cell Metab. 9:407–416. 2009. View Article : Google Scholar : PubMed/NCBI
39	Ceddia RB: The role of AMP-activated protein kinase in regulating white adipose tissue metabolism. Mol Cell Endocrinol. 366:194–203. 2013. View Article : Google Scholar : PubMed/NCBI
40	Piao GC, Liu GC, Jin XJ, Jin D and Yuan HD: Tetrahydropalmatine inhibits lipid accumulation through AMPK signaling pathway in 3T3-L1 adipocytes. Mol Med Rep. 15:3912–3918. 2017. View Article : Google Scholar : PubMed/NCBI
41	Wang G, Wu B, Xu W, Jin X, Wang K and Wang H: The inhibitory effects of Juglanin on adipogenesis in 3T3-L1 adipocytes. Drug Des Dev Ther. 14:5349–5357. 2020. View Article : Google Scholar : PubMed/NCBI
42	Jefcoate CR, Wang S and Liu X: Methods that resolve different contributions of clonal expansion to adipogenesis in 3T3-L1 and C3H10T1/2 cells. Methods Mol Biol. 456:173–193. 2008. View Article : Google Scholar : PubMed/NCBI
43	Lee MS, Kim CT, Kim IH and Kim Y: Effects of capsaicin on lipid catabolism in 3T3-L1 adipocytes. Phytother Res. 25:935–939. 2011. View Article : Google Scholar : PubMed/NCBI
44	Tzeng TF and Liu IM: 6-gingerol prevents adipogenesis and the accumulation of cytoplasmic lipid droplets in 3T3-L1 cells. Phytomedicine. 20:481–487. 2013. View Article : Google Scholar : PubMed/NCBI
45	Guo LX, Chen G, Yin ZY, Zhang YH and Zheng XX: p-Synephrine exhibits anti-adipogenic activity by activating the Akt/GSK3β signaling pathway in 3T3-L1 adipocytes. J Food Biochem. 43:e130332019. View Article : Google Scholar : PubMed/NCBI